183.23
price up icon1.14%   2.06
after-market Dopo l'orario di chiusura: 181.50 -1.73 -0.94%
loading
Precedente Chiudi:
$181.17
Aprire:
$181.96
Volume 24 ore:
1.23M
Relative Volume:
1.33
Capitalizzazione di mercato:
$20.49B
Reddito:
$10.52B
Utile/perdita netta:
$999.00M
Rapporto P/E:
21.91
EPS:
8.3628
Flusso di cassa netto:
$1.22B
1 W Prestazione:
-1.92%
1M Prestazione:
-2.00%
6M Prestazione:
+5.57%
1 anno Prestazione:
+16.62%
Intervallo 1D:
Value
$179.53
$183.38
Intervallo di 1 settimana:
Value
$179.53
$197.55
Portata 52W:
Value
$148.70
$197.55

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
Nome
Quest Diagnostics Inc
Name
Telefono
(973) 520-2700
Name
Indirizzo
500 PLAZA DRIVE, SECAUCUS
Name
Dipendente
56,000
Name
Cinguettio
@QuestDX
Name
Prossima data di guadagno
2025-10-21
Name
Ultimi documenti SEC
Name
DGX's Discussions on Twitter

Confronta DGX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
183.23 20.54B 10.52B 999.00M 1.22B 8.3628
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
571.91 210.70B 43.74B 6.59B 6.17B 17.30
Diagnostics & Research icon
DHR
Danaher Corp
222.73 155.94B 24.27B 3.50B 4.86B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
638.60 50.97B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
147.46 41.30B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
219.91 37.17B 15.70B 1.24B 2.01B 6.9036

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-25 Downgrade Robert W. Baird Outperform → Neutral
2025-04-02 Iniziato Redburn Atlantic Buy
2025-03-04 Downgrade Citigroup Buy → Neutral
2025-01-06 Aggiornamento Leerink Partners Market Perform → Outperform
2024-12-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2024-12-10 Ripresa Jefferies Buy
2024-10-23 Aggiornamento Robert W. Baird Neutral → Outperform
2024-08-28 Ripresa Evercore ISI In-line
2024-07-10 Aggiornamento Citigroup Neutral → Buy
2024-02-26 Iniziato Leerink Partners Market Perform
2024-02-07 Aggiornamento Jefferies Hold → Buy
2024-01-03 Iniziato Barclays Equal Weight
2023-12-12 Aggiornamento BofA Securities Neutral → Buy
2023-06-29 Iniziato Piper Sandler Neutral
2023-05-02 Downgrade BofA Securities Buy → Neutral
2023-04-03 Aggiornamento Citigroup Sell → Neutral
2023-01-23 Iniziato Evercore ISI In-line
2022-11-17 Downgrade Citigroup Neutral → Sell
2022-08-22 Ripresa Morgan Stanley Equal-Weight
2022-04-04 Downgrade Citigroup Buy → Neutral
2022-02-23 Downgrade UBS Buy → Neutral
2022-02-02 Downgrade Jefferies Buy → Hold
2022-01-28 Downgrade Deutsche Bank Buy → Hold
2021-05-04 Aggiornamento UBS Neutral → Buy
2021-03-12 Downgrade Robert W. Baird Outperform → Neutral
2020-10-21 Aggiornamento Argus Hold → Buy
2020-07-29 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 Aggiornamento BofA Securities Neutral → Buy
2020-06-09 Aggiornamento Wells Fargo Underweight → Equal Weight
2020-06-02 Aggiornamento Deutsche Bank Hold → Buy
2020-04-28 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-04-27 Aggiornamento Citigroup Neutral → Buy
2020-04-27 Aggiornamento Wolfe Research Underperform → Peer Perform
2020-03-27 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-01-08 Iniziato Wells Fargo Underweight
2020-01-07 Downgrade Barclays Overweight → Equal Weight
2019-12-19 Aggiornamento BofA/Merrill Underperform → Neutral
2019-07-15 Downgrade Goldman Neutral → Sell
2019-04-02 Aggiornamento Jefferies Hold → Buy
2019-03-18 Ripresa Credit Suisse Neutral
2019-01-31 Downgrade Argus Buy → Hold
2019-01-17 Iniziato UBS Neutral
2019-01-03 Downgrade BofA/Merrill Neutral → Underperform
2018-12-03 Downgrade BofA/Merrill Buy → Neutral
2018-11-30 Downgrade Goldman Buy → Neutral
Mostra tutto

Quest Diagnostics Inc Borsa (DGX) Ultime notizie

pulisher
Oct 23, 2025

Argus Lifts Price Target on Quest Diagnostics to $210 From $195 - MarketScreener

Oct 23, 2025
pulisher
Oct 23, 2025

Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

How to escape a deep drawdown in Quest Diagnostics IncorporatedWeekly Trend Summary & Target Return Focused Picks - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail

Oct 23, 2025
pulisher
Oct 23, 2025

How supply chain issues affect Quest Diagnostics Incorporated stockMarket Weekly Review & Growth Focused Investment Plans - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

How dovish Fed policy supports Quest Diagnostics Incorporated stockPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

How currency fluctuations impact Quest Diagnostics Incorporated stockJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

What Fibonacci levels say about Quest Diagnostics Incorporated reboundWeekly Earnings Recap & Low Risk High Reward Ideas - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Can Quest Diagnostics Incorporated stock surprise with earnings upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

Barclays Maintains Quest Diagnostics (DGX) Equal-Weight Recommendation - Nasdaq

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Incorporated (DGX): A Bull Case Theory - MSN

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead (NYSE:DGX) - Seeking Alpha

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings - Benzinga

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Sees Solid Demand Even As Margins Slip - Finimize

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Margins a Blip as Fundamentals Stay Strong, Morgan Stanley Says - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock - sharewise.com

Oct 22, 2025
pulisher
Oct 22, 2025

Barclays Lifts Price Target on Quest Diagnostics to $195 From $190, Maintains Equalweight Rating - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics Reports Third Quarter 2025 Financial Results, Raises Guidance for Full Year 2025 - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Morgan Stanley Raises Price Target on Quest Diagnostics to $207 From $191, Keeps Overweight Rating - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics (DGX): 15.4% Earnings Growth Challenges Slower-Growth Narrative - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

Quest Diagnostics: Q3 Earnings Snapshot - Stamford Advocate

Oct 22, 2025
pulisher
Oct 22, 2025

Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus

Oct 22, 2025
pulisher
Oct 21, 2025

Can Quest Diagnostics Incorporated (QDI) stock retain market dominance2025 Price Action Summary & Momentum Based Trading Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Will Quest Diagnostics Incorporated stock profit from fiscal stimulus2025 Dividend Review & Breakout Confirmation Trade Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Jefferies Maintains Quest Diagnostics (DGX) Buy Recommendation - Nasdaq

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Inc (DGX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada

Oct 21, 2025
pulisher
Oct 21, 2025

Published on: 2025-10-21 17:43:02 - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Leerink Partners Raises Price Target for Quest Diagnostics (DGX) to $210 | DGX Stock News - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Why Quest Diagnostics Incorporated stock is a strong buy call2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Inc (DGX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Inc (DGX) Q3 2025 Earnings Call Highlights: St - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Leerink Partners Adjusts PT on Quest Diagnostics to $210 From $203, Maintains Outperform Rating - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Reports Q3 Earnings, Shares Slide - Benzinga

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Incorporated Revises Financial Guidance for the Full Year Ending December 31, 2025 - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010. - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Fertility Test Market Report 2025-2033, with Profiles of Quest Diagnostics, Mayo Clinic Laboratories, Ovation Fertility, Illume Fertility, Proov, BioMerieux, Labcorp, CCRM Fertility, and Maven Clinic - GlobeNewswire Inc.

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics shares rise as strong clinical demand drives earnings beat - Investing.com Australia

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics (DGX) Surpasses Q3 Earnings and Revenue Estimates - sharewise.com

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise - TradingView

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Ups Forecasts As Diagnostic Test Demand Rises - Finimize

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Q3 2025 Earnings: Revenue Surpasses Estimates at $2.82 Billion, Adjusted EPS at $2.60 - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Q3 Adjusted Earnings, Revenue Rise; Annual Outlook Upgraded -- Shares Up Pre-Bell - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Delivers Strong Growth And Raises Guidance - Finimize

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics raises annual profit and revenue forecasts on lab test demand - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics (DGX) Exceeds Q3 Projections with Strong Finan - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Quest (NYSE:DGX) Posts Better-Than-Expected Sales In Q3 - The Globe and Mail

Oct 21, 2025
pulisher
Oct 21, 2025

(DGX) Quest Diagnostics Expects 2025 Net Revenue Range $10.96B$11.00B, vs. FactSet Est of $10.87B - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Q3 revenue beats estimates on higher demand - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Reports Third Quarter 2025 Financial Results - TradingView

Oct 21, 2025
pulisher
Oct 21, 2025

Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 - PR Newswire

Oct 21, 2025

Quest Diagnostics Inc Azioni (DGX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research WAT
$355.68
price up icon 2.01%
diagnostics_research LH
$284.00
price up icon 0.41%
$195.00
price up icon 3.71%
diagnostics_research MTD
$1,437.75
price up icon 4.08%
diagnostics_research IQV
$219.91
price up icon 0.94%
Capitalizzazione:     |  Volume (24 ore):